Selective Activation of ABCA1/ApoA1 Signalling in the Primary Visual Cortex by Magnetoelectric Stimulation Rapidly Ameliorates Depression-Like Behaviours Via Regulation of Synaptic Plasticity

Qingbo Lu,Fangfang Wu,Jiao,Le Xue,Ruize Song,Yachen Shi,Yan Kong,Jianfei Sun,Ning Gu,Ming-Hu Han,Zhijun Zhang

DOI: https://doi.org/10.2139/ssrn.3974117

2021-01-01

SSRN Electronic Journal

Abstract:Emerging evidence suggests that dysfunctional visual cortex maybe involved in the pathologies of major depressive disorder (MDD). However, the underlying mechanisms has yet to be fully clarified. We previously established that novel combined magnetic stimulation system treatment (c-MSST), in which superparamagnetic iron oxide (SPIO) nanoparticles were accurately microinjected to the left prelimbic (PrL) cortex under pulsed electromagnetic fields, displayed antidepressant effect in mice. Therefore, we further explore the antidepressant actions and underlying mechanisms of c-MSST targeting primary visual cortex (V1) in depression mouse models .We employed the c-MSST to precisely stimulated left V1in the mice treated with chronic unpredictable mild stress (CUMS) or lipopolysaccharide (LPS), and determined c-MSST effects on depression-like behaviours assessed by sucrose preference, forced swim, and tail suspension tests. Combining proteomics, bioinformatics and neurobiological techniques, we then determined the underlying neural mechanisms of c-MSST-induced antidepressant effects. V1-targeted c-MSST induced rapidly and significantly antidepressant effects in CUMS- and LPS-treated mice. Proteomic screening investigation and repeatable validation revealed that expression of V1 neuronal ATP-binding cassette transporter A1 (ABCA1) and apolipoprotein A-1 (ApoA1) was downregulated in CUMS mice as compared to control, an effect that was normalised by c-MSST. Consistently, neuron-specific knockdown of ABCA1 in V1 induced depression-like behaviours and blocked c-MSST-induced significantly antidepressant effects. Mechanistically, CUMS reduced dendritic spine density and long-term plasticity in V1, the deficits that were reversed by c-MSST. Furthermore, these reversal effects were blocked by ABCA1 knockdown in V1 of CUMS mice. V1-targeted c-MSST induces rapidly antidepressant effects, which are mediated by alterations in synaptic plasticity via ABCA1/ApoA1 signalling pathway in V1. These findings provide novel insights into the molecular and physiological mechanisms underlying c-MSST.